Entrada Therapeutics, Inc. (TRDA)
6.49
-9.54
(-59.51%)
USD |
NASDAQ |
May 07, 13:21
Entrada Therapeutics Market Cap : 248.47M for May 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Tyra Biosciences, Inc. | 1.743B |
| Biogen, Inc. | 27.99B |
| EyePoint, Inc. | 1.105B |
| Vertex Pharmaceuticals, Inc. | 108.44B |
| Arcutis Biotherapeutics, Inc. | 2.563B |
Market Cap Related Metrics
| PS Ratio | 10.56 |
| Price to Book Value | 0.8116 |
| Price | 6.49 |
| Earnings Yield | -53.48% |